A federal judge has ruled that medical device maker Medtronic Inc. must go to trial against claims that its Infuse bone growth product caused a woman to suffer serious and permanent injuries.
Court documents show that U.S. District Judge G. Murray Snow has denied in part a motion on behalf of Medtronic to dismiss the lawsuit pending in an Arizona court that its Infuse bone growth product was responsible for the woman’s injuries. Medtronic was seeking to use a federal law to supersede a state product liability lawsuit.
Medtronic was hoping to use a federal law that states a medical device company like itself is protected from consumer liability laws in a given state if the U.S. Food and Drug Administration (FDA) deemed its product to be safe prior to its being launched on the market.
Based on our reports, the Infuse bone growth product manufactured by Medtronic Inc. has been linked to myriad injuries among people who’ve received this product in lieu of a traditional bone graft in a spinal fusion or back surgery. Among the complications reported in lawsuits against the company are that the Infuse bone graft product caused excessive bone growth where it was implanted, which led to serious and sometimes permanent or life-threatening injuries. Excessive bone growth can be painful and if that growth is caused near a person’s airway, it could make breathing and swallowing very difficult and sometimes life-threatening.
The woman represented by the lawsuit in Arizona claims that she suffered serious injuries after Infuse was used in her lumbar fusion surgery in 2009. After that surgery, the woman began suffering from numerous complications she blames on Infuse. She claims that Medtronic failed to warn of the dangers of its bone growth product and that it was promoted for an off-label, unapproved use in her surgery, according to court documents.